Evidence map›Paper›PMID 20060833›Full record

ArticleJournal of immunological methods2010

Overcoming the hurdles in using mouse genetic models that block TGF-beta signaling.

Shomyseh Sanjabi, Richard A Flavell

Open access · greenAbstract read
In one paragraph

Article in Journal of immunological methods, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shomyseh SanjabiYale University School of Medicine, New Haven, CT 06520, USA.
Richard A Flavell
Yale University · US

Funding

Yale SPORE in Skin CancerP50CA121974 · NCI · YALE UNIVERSITY · PI DAVID F STERN · 2006 to 2026
$43.9M
PATHOGENESIS AND PREVENTION OF AUTOIMMUNE DIABETESR01DK051665 · NIDDK · YALE UNIVERSITY · PI FLAVELL, RICHARD A · 1996 to 2011
$3.2M
Howard Hughes Medical InstituteNCI NIH HHS CA121974NCI NIH HHS P50 CA121974NIDDK NIH HHS DK051665NIDDK NIH HHS R01 DK051665
6 · The paper itself

Abstract

The recent recognition of the importance of transforming growth factor beta (TGF-beta) in mediating many cellular immune functions has popularized the use of mouse models where TGF-beta signaling is blocked in specific cell types. However, there are some caveats affiliated with each model. Here we describe and show evidence for some of the limitations of these models and provide insight into ways to improve the utility of these animals for in vivo studies.

Indexed as

Adoptive TransferAnimalsCD11c AntigenCD4 AntigensCell SurvivalEpitopesGenes, RAG-1Genes, T-Cell ReceptorGenotypeImmunity, CellularListeria monocytogenesMiceMice, Inbred C57BLMice, TransgenicModels, AnimalOvalbuminCD11c AntigenCD4 AntigensEpitopesOVA-8OvalbuminPeptide FragmentsProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IITransforming Growth Factor beta

Identifiers

PMID20060833
PMCPMC2845397
OpenAlexW2091936724

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.